drugset / Trial / NCT00829894

Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions

NCT00829894

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to compare the rate and extent of absorption of risperidone 1 mg tablets (test) versus Risperdal® (reference) administered as a 1 x 1 mg tablets under fed conditions.

Timeline

Start
2001-06
Primary completion
2001-07
Completion
2001-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Risperidone Other / unclassified 1 mg

Indications

No indication recorded.